Search results
Biotech Stock Roundup: BMY's Q3 Results, PTCT Up on Deal, BEAM's Restructuring News
Zacks via Yahoo Finance· 6 months agoIt was a busy week for the biotech sector as the third-quarter earnings kicked in. Bristol Myers BMY...
Biotech Stock Roundup: GSK's Drug Approval, MRNA's Vaccine News, PTCT & SPRY Down
Zacks via Yahoo Finance· 7 months agoIt was a busy week for the biotech sector, with a lot of important regulatory and pipeline updates....
PTC Therapeutics (PTCT) Down on Negative CHMP Opinion for DMD Drug
Zacks via Yahoo Finance· 7 months agoPTC Therapeutics (PTCT) plunges on negative opinion from the Committee for Medicinal Products for...
PTC Therapeutics' (PTCT) Rare Disease Drug Fails in Study
Zacks via Yahoo Finance· 11 months agoPTC Therapeutics' (PTCT) vatiquinone did not achieve its primary endpoint in a late-stage study in...
Biotech Stock Roundup: IRWD Announces Buyout, ICPT, SRPT & PTCT Fall on Updates
Zacks via Yahoo Finance· 11 months agoThe biotech sector has been in focus in the past week with key pipeline and regulatory updates....
PTC Therapeutics (PTCT) Lost 16% in Q2
Insider Monkey via Yahoo Finance· 7 months agoTimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” second-quarter investor letter. A...
1 of Sarepta Therapeutics' Competitors Just Got Hammered. Will It Help the Stock?
Motley Fool via Yahoo Finance· 3 months agoIn biotech, it's often difficult to tell whether bad news for one company will also be bad news for...
Biotech Stock Roundup: GERN, CRNX Gain on Updates, BMY's CAR T Cell Therapy News & More
Zacks via Yahoo Finance· 1 month agoIt was a busy week for the biotech sector with lots of study data readouts and regulatory approvals....
The Zacks Analyst Blog Highlights Arcellx, Bristol Myers Squibb, Solid Biosciences, Vertex...
Zacks via Yahoo Finance· 6 months agoFor Immediate Release Chicago, IL – November 17, 2023 – Zacks.com announces the list of stocks...
Untapped Potential: 3 Stocks Tackling the Toughest Rare Diseases
InvestorPlace via Yahoo Finance· 8 months agoRare disease stocks have a difficult task. The rarer a disease is, the less public research goes...
